Preferred Label : Target Lesion Identification;

NCIt related terms : target lesion; target_lesion; TARGET; Index;

NCIt definition : The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention.;

Alternative definition : CDISC: The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention.;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3536022/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-des-tumeurs-stromales-gastro-intestinales-rapport-d-evaluation
2025
false
false
false
France
health technology assessment
Panel Device
Regulatory Report
High Level
Digestive System Neoplasm
Charge
sequence determinations
sequence analysis
Physical Examination
Target Lesion Identification
Target
Nucleic Acid Sequencing
intestinal tract, nos
IPSS-R Risk Category High
Topical Route of Administration
genes
High Mitosis-Karyorrhexis Index
Assessment
albumin/globulin ratio
Backflow
IPSS Risk Category High
High-Frequency Microsatellite Instability
Value Above Reference Range
Ratio
evaluation studies as topic
Topical Dosage Form
Evaluation
Assessment
patient care management
evaluation report
gastrointestinal stromal tumors
Has_Target
Output

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-permettant-de-baliser-le-recours-au-sequencage-pangenomique-par-rapport-au-sequencage-cible-dun-nombre-limite-de-genes-pour-la-recherche-de-variants-germinaux.html
2024
Canada
technical report
policy
sequence analysis
Limited Lifting Ability
Limited
genes
Has_Target
Criterion
Limited Walking Ability
Number
albumin/globulin ratio
Target
research report
medical futility
principle-based ethics
Ratio
Target Lesion Identification
Regulatory Report
Nucleic Acid Sequencing
sequence determinations

---
https://www.has-sante.fr/jcms/p_3536003/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-de-la-leucemie-lymphoide-chronique-rapport-d-evaluation
2024
France
health technology assessment
leukemia, lymphocytic, chronic, B-Cell
IPSS-R Risk Category High
Physical Examination
Has_Target
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
albumin/globulin ratio
Target
evaluation report
patient care management
sequence analysis
Panel Device
leukemia, lymphoid
Output
High Level
Assessment
Target Lesion Identification
genes
leukaemia
Topical Dosage Form
Assessment
sequence determinations
chronic lymphocytic leukemia
IPSS Risk Category High
High Mitosis-Karyorrhexis Index
Topical Route of Administration
Evaluation
Charge
Ratio
Backflow
Chronic Lymphocytic Leukemia
High-Frequency Microsatellite Instability
Regulatory Report
Value Above Reference Range
evaluation studies as topic
Nucleic Acid Sequencing

---
https://dumas.ccsd.cnrs.fr/dumas-04552300
2024
France
dissertations, academic
socialism
health
Evolution
student, nos
Target
Representation
students
Has_Target
Social Setting
Software Service
nurse administrators
Target Lesion Identification
Department
Public
Representation Component

---
https://www.has-sante.fr/jcms/p_3535386/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-du-cancer-du-poumon-recherche-des-alterations-moleculaires-somatiques
2024
France
health technology assessment
Impairment
IPSS Risk Category High
lung neoplasms
sequence determinations
Has_Target
Nucleic Acid Sequencing
Topical Route of Administration
Output
Value Above Reference Range
Cancer Research
Lung Carcinoma
neoplasm, malignant
Cancer Burden
medical research
Backflow
Somatic
Topical Dosage Form
Molecular
genes
Panel Device
IPSS-R Risk Category High
biomedical research
High-Frequency Microsatellite Instability
Alteration
Target
lung cancer
sequence analysis
High Level
High Mitosis-Karyorrhexis Index
Target Lesion Identification
patient care management

---
https://iris.who.int/bitstream/handle/10665/375917/9789240079519-fre.pdf?sequence=1&isAllowed=y
2023
Switzerland
technical report
Profile
Laboratory Procedure
Product Part
smallpox
smallpox, nos
diagnosis
Diagnosis Code
no diagnosis
Pharmacologic Substance
Mpox, Monkeypox
Target Lesion Identification
Date of Diagnosis
Target
Diagnosis Study
Smallpox
Has_Target

---
Nous contacter.
29/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.